Brown V - Search Results

1

Trends in the delivery of care to oncology patients in the United States: Emphasis on the role pharmacists on the healthcare team.

Ignoffo RJ, Knapp KK, Seung A, Brown V, Hough S, Rieband G, Dang TO, Palumbo A, Urmanski A. Ignoffo RJ, et al. Among authors: brown v. J Oncol Pharm Pract. 2021 Jan;27(1):5-13. doi: 10.1177/1078155220907674. Epub 2020 Apr 1. J Oncol Pharm Pract. 2021. PMID: 32237957

2

Comparison of enteral and parenteral methods of urine alkalinization in patients receiving high-dose methotrexate.

Rouch JA, Burton B, Dabb A, Brown V, Seung AH, Kinsman K, Holdhoff M. Rouch JA, et al. Among authors: brown v. J Oncol Pharm Pract. 2017 Jan;23(1):3-9. doi: 10.1177/1078155215610914. Epub 2016 Jun 23. J Oncol Pharm Pract. 2017. PMID: 26467268

3

Evaluation of the head and neck cancer patient population and the incidence of hospitalization at an academic medical center.

Hazelden LA, Newman MJ, Shuey S, Waldfogel JM, Brown VT. Hazelden LA, et al. J Oncol Pharm Pract. 2019 Mar;25(2):333-338. doi: 10.1177/1078155217735688. Epub 2017 Oct 19. J Oncol Pharm Pract. 2019. PMID: 29050538

4

Establishing an investigational drugs and research residency at an academic medical center.

Wascher M, Mighty J, Brown V, Ashby D, Rudek MA, Nesbit T, DeLisa A, Walker C, Tolan M. Wascher M, et al. Among authors: brown v. Am J Health Syst Pharm. 2019 Oct 30;76(22):1862-1867. doi: 10.1093/ajhp/zxz175. Am J Health Syst Pharm. 2019. PMID: 31518385 Free PMC article.

5

Multiple myeloma maintenance therapy: a review of the pharmacologic treatment.

Shank BR, Brown VT, Schwartz RN. Shank BR, et al. J Oncol Pharm Pract. 2015 Feb;21(1):36-51. doi: 10.1177/1078155213514468. Epub 2014 Jan 6. J Oncol Pharm Pract. 2015. PMID: 24395544 Review.

6

Factors associated with optimized tacrolimus dosing in hematopoietic stem cell transplantation.

Butts AR, Brown VT, McBride LD, Bolaños-Meade J, Bryk AW. Butts AR, et al. J Oncol Pharm Pract. 2016 Apr;22(2):275-83. doi: 10.1177/1078155215577809. Epub 2015 Mar 22. J Oncol Pharm Pract. 2016. PMID: 25802301 Free PMC article.

7

Novel Approach Using Administrative Claims to Evaluate Trends in Oncology Multigene Panel Testing for Patients Enrolled in Medicare Advantage Health Plans.

Caplan EO, Wong WB, Ferries E, Hulinsky R, Brown VT, Bordenave K, Suehs BT. Caplan EO, et al. JCO Precis Oncol. 2021 May 5;5:PO.20.00422. doi: 10.1200/PO.20.00422. eCollection 2021. JCO Precis Oncol. 2021. PMID: 34036226 Free PMC article.

8

Assessing health literacy to identify patients for pharmacist-provided counseling on high-risk medications.

Brown VT, LeBlanc YC, Efird LE, Nesbit T, Wellman JC, Feldman L. Brown VT, et al. Am J Health Syst Pharm. 2011 Sep 15;68(18):1692-3. doi: 10.2146/ajhp100692. Am J Health Syst Pharm. 2011. PMID: 21880881 No abstract available.

9

Analysis of FDA approvals of targeted anticancer combination regimens.

Brown VT, Cho V, Parkey S. Brown VT, et al. Am J Health Syst Pharm. 2017 Dec 1;74(23):1938-1942. doi: 10.2146/ajhp170029. Am J Health Syst Pharm. 2017. PMID: 29167134 No abstract available.

10

Real-World Incidence and Management of Immune-Related Adverse Events from Immune Checkpoint Inhibitors: Retrospective Claims-Based Analysis.

Brown VT, Antol DD, Racsa PN, Ward MA, Naidoo J. Brown VT, et al. Cancer Invest. 2021 Nov;39(10):789-796. doi: 10.1080/07357907.2021.1913502. Epub 2021 Sep 27. Cancer Invest. 2021. PMID: 33829943

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,072 results

Search Page

Filters